GlassScriptPhysician profile
Jillian L Boyd
NPI 1134612450
$1,563.70
in general payments reported to CMS, 2019-2025
12 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $329 · 2020: $151 · 2021: $171 · 2022: $73.36 · 2023: $132 · 2024: $552 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $839.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $839.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb, A Division of Bausch Health US, LLC | $625.04 | 2019-2021 | |
| Biotissue Holdings INC. | $339.16 | 2024 | |
| Sun Pharmaceutical Industries INC. | $289.15 | 2022-2024 | Cequa |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2025 | Eylea Hd |
| Bausch & Lomb Americas INC. | $50.39 | 2022-2025 | Infuse, Vyzulta, Miebo |
| Tarsus Pharmaceuticals, INC. | $25.87 | 2024 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $24.27 | 2019-2022 | |
| Amgen INC. | $21.58 | 2024 | Tepezza |
| Thea Pharma INC. | $19.87 | 2023 | |
| Glaukos Corporation | $15.76 | 2022 | |
| Aerie Pharmaceuticals, INC. | $14.01 | 2019 | |
| Alcon Vision LLC | $13.60 | 2025 | Precision7 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jillian Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.